Proteomics International Laboratories Ltd
ASX:PIQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Proteomics International Laboratories Ltd
Other Liabilities
Proteomics International Laboratories Ltd
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Other Liabilities
AU$1.4m
|
CAGR 3-Years
20%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Other Liabilities
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Anteotech Ltd
ASX:ADO
|
Other Liabilities
AU$602.8k
|
CAGR 3-Years
-1%
|
CAGR 5-Years
83%
|
CAGR 10-Years
20%
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Other Liabilities
AU$412k
|
CAGR 3-Years
8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Other Liabilities
AU$9.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
9%
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Other Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Proteomics International Laboratories Ltd
Glance View
Proteomics International Laboratories Ltd. is a medical technology company which operates at the forefront of predictive diagnostics and bio-analytical services. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2015-04-16. The firm is engaged in predictive diagnostics and bio-analytical services. The firm specializes in proteomics, the study of the structure and function of proteins. The firm focuses on developing and commercializing diagnostic tests for chronic diseases. The firm operates in three business units unified by a technology platform: PromarkerD, Diagnostics and Analytical Services. PromarkerD is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes. Diagnostics includes Promarker platform, used to discover, verify, and analytically validate the panel of protein biomarkers for diabetic kidney disease. Analytical Services includes proteomics-based technology platform, used to test, and validate the protein composition of a wide and varied range of products.
See Also
What is Proteomics International Laboratories Ltd's Other Liabilities?
Other Liabilities
1.4m
AUD
Based on the financial report for Dec 31, 2025, Proteomics International Laboratories Ltd's Other Liabilities amounts to 1.4m AUD.
What is Proteomics International Laboratories Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
34%
Over the last year, the Other Liabilities growth was 226%. The average annual Other Liabilities growth rates for Proteomics International Laboratories Ltd have been 20% over the past three years , 34% over the past five years .
